ICON Public (NASDAQ:ICLR – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $14.65-$15.15 for the period, compared to the consensus earnings per share estimate of $14.94. The company issued revenue guidance of $8.48-$8.72 billion, compared to the consensus revenue estimate of $8.64 billion.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on ICLR. Barclays lifted their target price on shares of ICON Public from $325.00 to $355.00 and gave the stock an overweight rating in a report on Friday, February 23rd. Mizuho restated a buy rating and issued a $346.00 price target on shares of ICON Public in a research report on Thursday, April 4th. Evercore ISI raised their price target on shares of ICON Public from $325.00 to $350.00 and gave the stock an outperform rating in a research report on Friday, February 23rd. Robert W. Baird raised their price target on shares of ICON Public from $345.00 to $362.00 and gave the stock an outperform rating in a research report on Thursday, April 4th. Finally, Truist Financial raised their price target on shares of ICON Public from $357.00 to $367.00 and gave the stock a buy rating in a research report on Friday, February 23rd. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, ICON Public presently has an average rating of Moderate Buy and an average price target of $319.45.
Check Out Our Latest Report on ICON Public
ICON Public Price Performance
ICON Public (NASDAQ:ICLR – Get Free Report) last announced its quarterly earnings results on Wednesday, February 21st. The medical research company reported $3.40 earnings per share for the quarter, topping analysts’ consensus estimates of $3.27 by $0.13. ICON Public had a net margin of 7.54% and a return on equity of 11.42%. The company had revenue of $2.07 billion for the quarter, compared to analysts’ expectations of $2.08 billion. Research analysts forecast that ICON Public will post 14.4 EPS for the current year.
ICON Public Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Further Reading
- Five stocks we like better than ICON Public
- How to Calculate Stock Profit
- Hasbro’s Management Made All the Right Calls This Quarter
- Investing in Construction Stocks
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Market Cap Calculator: How to Calculate Market Cap
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.